Literature DB >> 9377725

Renal effects of insulin in man.

A Quiñones-Galvan1, E Ferrannini.   

Abstract

We review some of the effects that insulin exerts on glomerular and tubular functions. In healthy subjects, insulin has little or no effect on renal hemodynamics, glomerular filtration rate, or permeability to albumin. In patients with noninsulin-dependent diabetes, hyperinsulinemia selectively increases urinary albumin excretion. In vivo, euglycemic hyperinsulinemia is associated with reduced urinary sodium excretion both under conditions of forced and normal diuresis. Whether the principal site of this action is the proximal or distal tubule remains somewhat controversial. The effect, however, is not mediated by insulin-induced hypokalemia and antikaliuresis, as it is still observed when plasma potassium concentrations and urinary potassium excretion are maintained. Hyperglycemia potentiates insulin antinatriuresis through an effect on the proximal tubule (sodium-glucose cotransport). Insulin antinatriuresis is accompanied by a reduction in the urinary excretion of uric acid. Both the antinatriuretic and antiuricosuric effect of insulin are preserved in states of insulin resistance of glucose metabolism (obesity, diabetes, essential hypertension). Thus, in insulin resistant individuals compensatory hyperinsulinemia imposes a chronic antinatriuretic and antiuricosuric pressure on the kidney. This may provide an explantation for the clustering of insulin resistance with hypertension and hyperuricemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9377725

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  21 in total

Review 1.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Gout and Metabolic Syndrome: a Tangled Web.

Authors:  Gabrielle E Thottam; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Curr Rheumatol Rep       Date:  2017-08-26       Impact factor: 4.592

3.  A case of insulin edema with inappropriate hyperaldosteronism.

Authors:  G Kalambokis; A Tsatsoulis; G Economou; E V Tsianos
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

4.  Angiotensin II inhibits insulin-stimulated phosphorylation of eukaryotic initiation factor 4E-binding protein-1 in proximal tubular epithelial cells.

Authors:  D Senthil; J L Faulkner; G G Choudhury; H E Abboud; B S Kasinath
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

5.  Determination of early urinary renal injury markers in obese children.

Authors:  Nilufer Goknar; Faruk Oktem; Ilker Tolga Ozgen; Emel Torun; Mehmet Kuçukkoc; Aysegul Dogan Demir; Yasar Cesur
Journal:  Pediatr Nephrol       Date:  2014-05-07       Impact factor: 3.714

6.  Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout.

Authors:  Tahzeeb Fatima; Sara Altaf; Amanda Phipps-Green; Ruth Topless; Tanya J Flynn; Lisa K Stamp; Nicola Dalbeth; Tony R Merriman
Journal:  Rheumatol Int       Date:  2015-09-26       Impact factor: 2.631

Review 7.  Obesity-related cardiorenal disease: the benefits of bariatric surgery.

Authors:  Wiebke Fenske; Thanos Athanasiou; Leanne Harling; Christiane Drechsler; Ara Darzi; Hutan Ashrafian
Journal:  Nat Rev Nephrol       Date:  2013-08-06       Impact factor: 28.314

Review 8.  Parenteral nutrition in the critically ill patient.

Authors:  Thomas R Ziegler
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

9.  Reduced ENaC activity and blood pressure in mice with genetic knockout of the insulin receptor in the renal collecting duct.

Authors:  Lijun Li; R Mayuri Garikepati; Susanna Tsukerman; Donald Kohan; James B Wade; Swasti Tiwari; Carolyn M Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2012-11-28

10.  The association between hyperuricemia and the Trp64Arg polymorphism of the beta-3 adrenergic receptor.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2007-01-16       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.